Andere talen Pharmaron Beijing Co., Ltd.

Aandelen

300759

CNE100003JW4

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 18-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
19,96 ^CNY	-2,59%		+2,10%	-31,12%

20/05	Eenheid van Pharmaron Beijing verkoopt aandeel Proteologix aan Johnson & Johnson	MT
30/04	Pharmaron Beijing's winst stijgt met 17% in 2023	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Pharmaron Beijing Co., Ltd. Approves Final Dividend for the Financial Year Ended December 31, 2023, Payable on July 26, 2024	06/06
Pharmaron Beijing Unit to Sell Proteologix Stake to Johnson & Johnson	20/05
Johnson & Johnson entered into a definitive agreement to acquire Proteologix, Inc. from Pharmaron Beijing Co., Ltd and other shareholders for approximately $100 million.	16/05
Pharmaron Beijing's Profit Rises 17% in 2023	30/04
Pharmaron Beijing Posts 34% Profit Drop in Q1 as Revenue Slips 2%	26/04
Pharmaron Beijing To Repurchase Shares Worth Up To 300 Million Yuan; Shares Jump 8%	26/04
Pharmaron Beijing Co., Ltd. announces an Equity Buyback for CNY 300 million worth of its shares.	25/04
Pharmaron Beijing Co., Ltd. Announces Executive Changes	25/04
Pharmaron Beijing Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Pharmaron Beijing Co., Ltd. authorizes a Buyback Plan.	25/04
Pharmaron Partners Seven Firms to Float 2 Billion Yuan Fund	08/04
Pharmaron's 2023 Profit, Revenue Rise; Misses Estimates	28/03
Pharmaron Beijing Co., Ltd. Proposes Final Dividend for the Financial Year Ended December 31, 2023, Payable on 26 July 2024	27/03
Pharmaron Beijing Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Caída de cuchillos, Air Astana y extremismo	29/01
Pharmaron Beijing Sees Up to 14% Jump in 2023 Profit	29/01
Pharmaron Forecasts Up to 19% Rise in 2023 Attributable Profit	29/01
Pharmaron Beijing Co., Ltd. Provides Earnings Guidance for the Financial Year Ended December 31, 2023	28/01
Pharmaron Beijing Buys Back Additional Series 2 Bonds	15/01
Pharmaron Beijing Buys Back $68 Million of Convertible Bonds Due 2026	12/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Pharmaron Beijing Co., Ltd.

Aandelen

300759

CNE100003JW4

Andere talen

Filters